184 studies found for:    "Aplastic anemia"
Show Display Options
Rank Status Study
1 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment
Intervention: Drug: Eltrombopag
2 Completed A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Neutropenia;   Pancytopenia;   Severe Aplastic Anemia;   Refractory Severe Aplastic Anemia
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine
3 Recruiting Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia;   Very Severe Aplastic Anemia;   Moderate Aplastic Anemia
Intervention: Drug: Eltrombopag
4 Active, not recruiting Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Neutropenia;   Pancytopenia;   Severe Aplastic Anemia
Interventions: Drug: Cyclophosphamide;   Drug: Cyclosporine
5 Recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath  )
6 Suspended Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alefacept
7 Completed Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
8 Withdrawn Alemtuzumab and Rituximab in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alemtuzumab and Rituximab
9 Active, not recruiting Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: cyclophosphamide,cyclosporine A
10 Completed Stem Cell Factor Medication for Aplastic Anemia
Conditions: Aplastic Anemia;   Pancytopenia
Intervention: Drug: Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)
11 Completed Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
12 Completed Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Intravenous bone marrow mesenchymal stem cells infusion
13 Not yet recruiting Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
Conditions: Dyskeratosis Congenita;   Aplastic Anemia
Interventions: Drug: Alemtuzumab;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Stem Cell Transplant;   Drug: Anti-thymocyte globulin
14 Completed
Has Results
Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Antithymocyte Globulin
15 Completed Comparing Therapies for the Treatment of Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Hematologic Disease
Interventions: Drug: Antithymocyte globulin & amp; Cyclosporin A;   Drug: Cyclophosphamide & amp;  Cyclosporin A
16 Completed Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Mycophenolate mofetil;   Drug: Cyclosporine
17 Terminated
Has Results
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cytoxan;   Drug: Campath;   Radiation: Total Body Irradiation (TBI);   Drug: FK-506;   Drug: Methotrexate;   Procedure: Stem cell infusion
18 Active, not recruiting Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Radiation: Total Body Irradiation (TBI);   Procedure: Bone Marrow Transplant
19 Recruiting Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
Condition: Aplastic Anemia
Intervention: Drug: ATG-fresenius
20 Active, not recruiting Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Alemtuzumab (Campath-1H);   Drug: Thymoglobulin (r-ATG);   Drug: Cyclosporine (CsA)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years